Neuromodulation has been a fast-growing area of medicine for at least a decade. Despite becoming an increasingly common way to treat chronic pain, neurological disorders, and even psychiatric ...
The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed by a randomized, double-blinded, sham-controlled trial (30 patients).
Anyone who gets them will tell you: Migraines are the worst. Getting one means saying goodbye to at least the rest of your day, and possibly goodbye to your lunch, too. Unfortunately, there's not much ...
Neuromodulation — where an external or implanted pulse generator sends mild electric pulses to targeted nerves to achieve a certain therapeutic effect — has been gaining ground in recent years with ...
The specialist: Co-director of the Center for Neuromodulation at Mount Sinai, Dr. Brian Kopell is a neurosurgeon who specializes in implanting devices to alleviate chronic pain, psychiatric disorders ...
The brain has mechanisms and structures that could support learning mechanisms different from typical gradient-based optimization algorithms employed in artificial neural networks. The complex ...
Spurred by the opioid crisis, a once marginalized therapy that relies on electrical stimulation to treat chronic pain is undergoing a renaissance as device makers race to upgrade their products for a ...
As obstinate and frustrating as we are sometimes, humans in general are pretty flexible when it comes to learning—especially compared to AI. Our ability to adapt is deeply rooted within our brain’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results